Risk Management For Biotech Companies In Clinical Trials

Source: Q2 Solutions

In this episode, the second of a three-part series, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.

Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach. 
Alex and Alan talk about:

  • How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur.
  • What sponsors can do to reduce the risks for their study.
  • How Q2 Solutions' in-house scientific and regulatory expertise ensure that your data are compliant to global regulations.

access the Podcast!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader